Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market
Move strengthens market visibility, supports liquidity and real-time quote access as PT00114 advances toward Phase 2 in 2026 NEW YORK...
Day: March 10, 2026
Protara Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update
Reported interim data from ADVANCED-2 trial in non-muscle invasive bladder cancer (NMIBC); TARA-002 demonstrated 68% complete response rate at six...
Protara Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update
Reported interim data from ADVANCED-2 trial in non-muscle invasive bladder cancer (NMIBC); TARA-002 demonstrated 68% complete response rate at six...
Protara Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update
Reported interim data from ADVANCED-2 trial in non-muscle invasive bladder cancer (NMIBC); TARA-002 demonstrated 68% complete response rate at six...
Tonix Pharmaceuticals Presented Post Hoc Analyses of Phase 3 Data on TONMYATM at the 8th International Congress on Controversies in Fibromyalgia
Company launched TONMYA, approved by the FDA as a treatment for fibromyalgia, in November 2025 In post hoc analysis of...
Tonix Pharmaceuticals Presented Post Hoc Analyses of Phase 3 Data on TONMYATM at the 8th International Congress on Controversies in Fibromyalgia
Company launched TONMYA, approved by the FDA as a treatment for fibromyalgia, in November 2025 In post hoc analysis of...
Tonix Pharmaceuticals Presented Post Hoc Analyses of Phase 3 Data on TONMYATM at the 8th International Congress on Controversies in Fibromyalgia
Company launched TONMYA, approved by the FDA as a treatment for fibromyalgia, in November 2025 In post hoc analysis of...
Medicus Pharma Ltd. To Participate In The Longwood Miami CEO Forum
Dr. Raza Bokhari, Executive Chairman & CEO will participate in panel discussions and highlight Company's AI-enabled Drug Development Strategy PHILADELPHIA,...
electroCore to Participate at the 38th Annual Roth Conference
ROCKAWAY, N.J., March 10, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a bioelectronic medicine and wellness company, announced today...
electroCore to Participate at the 38th Annual Roth Conference
ROCKAWAY, N.J., March 10, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a bioelectronic medicine and wellness company, announced today...
electroCore to Participate at the 38th Annual Roth Conference
ROCKAWAY, N.J., March 10, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a bioelectronic medicine and wellness company, announced today...
Zomedica to Review 2025 Financial Results and Highlight Equine Market Opportunity During March 27th “Fourth Friday at Four” Investor Webinar
Webinar will include a review of full-year 2025 and fourth quarter 2025 financial results, a deep dive into the equine...
Aspargo Labs Gears Up to Bring Patented Liquid Erectile Dysfunction Treatment to UK Over-the-Counter Pharmacy Shelves
NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Aspargo Labs, Inc. (“Aspargo Labs” or the “Company”), a pharmaceutical company commercializing an...
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2025 Results
Record full-year total revenue and AVISE® CTD average selling price New biomarkers and sales force expansion drove over 11% full-year...
Daxor to Debut New Rapid, Portable Blood Volume Analyzer at SCCM 2026 Critical Care Congress
Advancing Precision Fluid Management in the ICU to Reduce Mortality and Hospital Length of Stay Oak Ridge, TN, March 10,...
New Report, “Let’s Talk Poop: Digestive Health, Denial, and the Cost of Staying Quiet,” Reveals Widespread Digestive Health Issues Accompanied By Stigma and Embarrassment
National data from Oshi Health reveals that 50% of Americans have gut issues, but a majority simply think treatable symptoms...
VTAK Announces Definitive Merger Agreement to Acquire 100% of Fly Flyte Inc.
Transaction Delivers Wholly Owned, Scalable Asset-Backed, Aviation Platform with Accelerating Revenue and Consolidated Control Positions VTAK at the Center of...
Cassava Sciences Announces Name Change to Filana Therapeutics, Inc.
New corporate identity reflects the Company’s mission to develop novel medicines to modulate filamin A and address unmet needs in...
Cynet Closes Record Year of Channel Growth
MSPs drive 64% of Q4 global deals as Cynet enters 2026 with accelerating channel momentumBOSTON, March 10, 2026 (GLOBE NEWSWIRE)...
MBX Biosciences Appoints Karen Basbaum as Chief Business Officer
CARMEL, Ind., March 10, 2026 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the...